胱抑素C在帕金森病進(jìn)展過程中的作用初步研究
發(fā)布時(shí)間:2019-06-06 05:01
【摘要】:目的:觀察帕金森。≒arkinson’s disease, PD)患者血清胱抑素C (cyststin C, cysC)水平的變化,探討其在PD進(jìn)展過程中的作用,分析影響其水平的因素。 第一部分:帕金森病患者血清胱抑素C的水平變化 方法:收集2011年7月至2012年12月在蘇州大學(xué)附屬第二醫(yī)院神經(jīng)內(nèi)科經(jīng)臨床確診為PD的患者115例,同時(shí)間段內(nèi)進(jìn)行健康體檢的110名健康中老年人作為對照組,檢測血清cys C及相關(guān)生化指標(biāo)。采用SPSS17.0軟件對數(shù)據(jù)進(jìn)行統(tǒng)計(jì)分析。 結(jié)果:PD組血清cys C平均水平為(1.06±0.20) mg/L,健康對照組為(0.96±0.16)mg/L,組間均數(shù)比較差異有統(tǒng)計(jì)學(xué)意義(t=6.663, P<0.05)。斯皮爾曼等級相關(guān)分析提示血清cys C水平只與年齡(r=0.381, P<0.001)、血肌酐(r=0.267, P=0.004)之間呈正相關(guān),與尿素、尿酸、膽固醇、甘油三酯、高密度脂蛋白(high density lipoprotein,HDL)、低密度脂蛋白(low density lipoprotein, LDL)沒有相關(guān)性(P>0.05)。方差分析提示中晚期PD患者的血清cys C水平較高(P<0.05)。 第二部分:合并阻塞性睡眠呼吸暫停綜合征的帕金森病患者血清胱抑素C水平的變化 方法:收集2011年7月至2013年12月期間在蘇州大學(xué)附屬第二醫(yī)院神經(jīng)內(nèi)科就診并完成多導(dǎo)睡眠監(jiān)測的PD患者56例,同時(shí)間段內(nèi)完成多導(dǎo)睡眠監(jiān)測的健康中老年人18名作為對照組。根據(jù)呼吸暫停低通氣指數(shù)(apnea hypopnea index, AHI)將56例PD患者分成兩組:PD合并阻塞性睡眠呼吸暫停綜合征(obstructive sleepapnea-hypopnea syndrome, OSAHS)組,26例;PD組,30例。所有研究對象進(jìn)行一般情況、運(yùn)動(dòng)功能、生物化學(xué)指標(biāo)、睡眠參數(shù)方面的檢測,采用SPSS17.0軟件分析并比較三組間上述指標(biāo)差異。 結(jié)果:PD合并OSAHS組血清cys C平均水平為1.05±0.17mg/L,PD組血清cysC平均水平為0.96±0.12mg/L,健康對照組血清cys C平均水平為0.84±0.20mg/L,組間均數(shù)比較差異有統(tǒng)計(jì)學(xué)意義(F=9.184, P<0.05),其中PD合并OSAHS組的血清cys C水平在三組中最高。在PD合并OSAHS組中,斯皮爾曼等級相關(guān)分析提示血清cys C水平與肌酐(r=0.459, P=0.018)、尿素(r=0.405, P=0.04)、AH(Ir=0.482, P=0.013)、氧減指數(shù)(oxygen desaturation index, ODI)(r=0.408, P=0.038)、呼吸相關(guān)微覺醒指數(shù)(r=0.392, P=0.047)、Hoehn-Yahr(HY)分期(r=0.469, P=0.016)之間呈正相關(guān),,與其他臨床指標(biāo)沒有相關(guān)性(P>0.05)。線性回歸提示肌酐(B=0.007, P=0.005)、AHI(B=0.004, P=0.013)、HY分期(B=0.102, P=0.026)是血清cys C水平變化的重要影響因素。 結(jié)論:PD患者血清cys C高于正常,中晚期患者其水平更高,合并OSAHS的PD患者夜間缺氧程度與血清cys C的水平呈正相關(guān)。因此,血清cys C可能可以作為神經(jīng)細(xì)胞損傷的標(biāo)志物。
[Abstract]:Objective: to observe the changes of serum cystine C (cyststin C, cysC) level in patients with Parkinson's disease (Parkinson's disease, PD), to explore its role in the progress of PD, and to analyze the factors affecting its level. Part I: changes of serum cystine C levels in patients with Parkinson's disease methods: from July 2011 to December 2012, 115 patients with PD diagnosed clinically in the Department of Neurology, the second affiliated Hospital of Suzhou University, were collected. At the same time, serum cys C and related biochemical indexes were measured in 110 healthy middle-aged and elderly people who underwent physical examination in the interval as control group. SPSS17.0 software is used to analyze the data. Results: the mean level of serum cys C in PD group was (1.06 鹵0.20) mg/L, and that in healthy control group was (0.96 鹵0.16) mg/L, there was significant difference between the two groups (t 鈮
本文編號:2494091
[Abstract]:Objective: to observe the changes of serum cystine C (cyststin C, cysC) level in patients with Parkinson's disease (Parkinson's disease, PD), to explore its role in the progress of PD, and to analyze the factors affecting its level. Part I: changes of serum cystine C levels in patients with Parkinson's disease methods: from July 2011 to December 2012, 115 patients with PD diagnosed clinically in the Department of Neurology, the second affiliated Hospital of Suzhou University, were collected. At the same time, serum cys C and related biochemical indexes were measured in 110 healthy middle-aged and elderly people who underwent physical examination in the interval as control group. SPSS17.0 software is used to analyze the data. Results: the mean level of serum cys C in PD group was (1.06 鹵0.20) mg/L, and that in healthy control group was (0.96 鹵0.16) mg/L, there was significant difference between the two groups (t 鈮
本文編號:2494091
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2494091.html
最近更新
教材專著